Azenta Cuts Scope 1 and 2 Emissions by 40% and Discloses Scope 3 Baseline in 2025 ESG Report

Azenta, a leading provider of life sciences solutions, has published its 2025 ESG report covering the fiscal year ended September 30, 2025, disclosing its Scope 3 greenhouse gas emissions for the first time and submitting near-term reduction targets to the Science Based Targets initiative for validation. The company reduced its Scope 1 and 2 carbon footprint by approximately 40 percent compared with a fiscal year 2022 baseline on a market-based basis while sourcing 72 percent of its electricity from renewable sources. The SBTi-submitted targets include a 45 percent absolute reduction in Scope 1 and 2 emissions and a 25 percent absolute reduction in Scope 3 emissions across key value chain categories by fiscal year 2033, from a fiscal year 2025 base year.

 

Scope 3 Disclosure and Science-Based Targets

 

The first-time disclosure of Scope 3 emissions represents a significant step in Azenta's climate transparency journey, establishing a value chain emissions baseline that provides the foundation for targeted reduction efforts and long-term climate action. For a life sciences company operating across cold-chain sample management, multiomics services and drug development support, upstream and downstream value chain emissions from supply chains, customer use of products and logistics are likely to represent the majority of the total carbon footprint. The baseline disclosure enables the company and its stakeholders to understand where emissions are concentrated and which reduction levers will deliver the greatest impact.

The submission of near-term SBTi targets covering both Scope 1 and 2 and Scope 3 emissions signals a move toward externally validated climate commitments rather than internal pledges alone. The 45 percent Scope 1 and 2 target and the 25 percent Scope 3 target over an eight-year period represent meaningful ambition for a company that has already achieved a 40 percent operational emissions reduction since fiscal year 2022. Achieving the Scope 3 target will require engagement with suppliers, customers and logistics partners to drive reductions across the value chain, building on the baseline now established.

 

Read more: Omnia and Casa dos Ventos Sign $2 Billion 20-Year Renewable Energy Deal to Power ByteDance Data Centre in Brazil

 

Renewable Energy Progress and Sustainable Innovation

 

Azenta sourced 72 percent of its electricity from renewable energy in fiscal year 2025, a significant share that reflects active procurement of renewable power across its global operations in North America, Europe and Asia. Continued expansion of renewable electricity procurement will be central to reaching the Scope 1 and 2 reduction target by fiscal year 2033, alongside energy efficiency improvements across the company's manufacturing and laboratory infrastructure. The company also advanced sustainable innovation through products such as the BioArc Ultra, a platform designed to provide customers with cutting-edge solutions for large-scale, eco-friendly sample storage.

Sustainable product innovation is increasingly important for life sciences equipment and service providers, as pharmaceutical and biotech customers face their own emissions reduction obligations and scrutinise the environmental footprint of their supply chains. By developing energy-efficient storage and sample management solutions, Azenta can help customers reduce their own Scope 3 emissions while simultaneously supporting its commercial growth objectives. This alignment between customer sustainability requirements and Azenta's product development agenda creates a commercially reinforcing dynamic for the company's sustainability investment.

 

Governance, Risk Management and Employee Wellbeing

 

Azenta refreshed its Enterprise Risk Management framework in 2025 with Board approval of updated risk assessment processes and clearer accountability across business units, strengthening the company's approach to enterprise and operational risk management. The ERM refresh ensures that climate and sustainability risks are embedded within the company's mainstream governance architecture rather than managed as a standalone function. Expanding the Azenta Business System across global operations equipped teams with tools and capabilities to improve quality, reduce waste and deliver better outcomes for customers, creating operational efficiency gains that support both financial performance and sustainability objectives.

The company completed its second annual Global Well-being Week, offering employees programming across physical, financial and mental well-being dimensions. Employee wellbeing programmes are increasingly recognised as a core component of social responsibility and talent retention strategy, particularly in life sciences where specialised technical expertise is a competitive differentiator. The combination of governance strengthening, operational improvement and employee engagement reflects a mature ESG programme that addresses environmental, social and governance dimensions in an integrated manner.

 

Explore OneStop ESG Marketplace: GHG Accounting

 

Outlook for Azenta's ESG Trajectory

 

The 2025 report positions Azenta as a life sciences company with credible and advancing sustainability commitments across all three ESG dimensions. Sustained progress on renewable electricity sourcing, combined with SBTi validation of the submitted targets, would strengthen the credibility of the company's climate strategy and support engagement with customers and investors who place increasing weight on supplier sustainability performance. Whether Azenta can achieve its fiscal year 2033 targets will depend on continued operational decarbonisation, the effectiveness of supplier and customer engagement on Scope 3 emissions and the trajectory of renewable energy availability across its global footprint.

The first-time Scope 3 disclosure is likely to become a defining feature of the company's stakeholder communications in the coming years as target validation and progress reporting become central to investor and customer sustainability assessments. Life sciences companies with strong cold-chain infrastructure and sample management capabilities face particular scrutiny on energy consumption given the continuous refrigeration requirements of their core operations. Azenta's progress on renewable electricity and operational emissions reduction suggests the company is building the operational foundation needed to meet its forward commitments credibly.

 

Source: PRNewswire